Medical Science Liaisons in Oncology (2016)

  • ID: 3920173
  • Report
  • Region: Global
  • 153 pages
  • Industry Standard Research (ISR)
1 of 5

FEATURED COMPANIES

  • AbbVie
  • AstraZeneca
  • Celgene
  • GSK
  • Merck & Co.
  • Pfizer
  • MORE
Biopharmaceutical research companies efforts to bring new, more effective treatments to market represent the world’s best hopes to provide oncologists with the drugs needed to give cancer patients longer, healthier lives and reduce the burden of the disease on society. To garner awareness, interest, and trial for any of oncological medications in development in the highly competitive US cancer drug market, biopharmaceutical manufacturers must develop sales/ information strategies that best serve oncologists’ needs. These strategies will certainly employ Medical Science Liaisons (MSLs) in addition to traditional sales representatives. The Medical Science Liaison in Oncology offers insights into how oncologists engage with 20 biopharmaceutical manufacturer’s MSLs. This report contains critical knowledge on how manufacturers can best engage oncologists in a drug’s story.

How You Can Use This Report:

Study Sponsors:

- Understand how US oncologists want to be engaged
- Learn which sales and marketing mix matches with what oncologists expect
- Discover the traits of the best MSLs and which biopharmaceutical firms field MSLs exceed or fail to meet oncologists’ expectations
- Uncover what type of interactions oncologists view as appropriate and effective boundaries not to cross when engaging with an oncologist.
- Pinpoint the information oncologists find most valuable and the best sales channels for delivering specific types of data/ information
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie
  • AstraZeneca
  • Celgene
  • GSK
  • Merck & Co.
  • Pfizer
  • MORE
1. Introduction

2. Methodology
- Respondent Profile
- Practice Area
- Years in Practice
- Types of Cancer Treated
- Primary Practice Setting
- Last MSL or Sales Rep Visit
- Number of Ratings per Company

3. Study Findings

4. Access To Oncologists
- Primary Findings
- Opportunities for Access
- Restriction Level
- Restrictions on Detailing
- MSL versus Rep versus eDetail
- Information of Most Interest to Oncologists
- Preferred MSL Traits
- Visit Activity
- Recent Visit Activity
- Visit Duration
- Firms Visiting Oncologists in Past 12 Months

5. MSL Performance
- Primary Findings
- Best MSLs
- Satisfaction with Interactions

6. The MSL Interaction Experience
- Primary Findings
- Discussion Topics
- Typical Topics Discussed
- Value of Topics Discussed
- Appropriateness of Topics Discussed

7. Information Strategies
- Primary Findings
- Preferred Source of Information
- Categories of Information
- Learning About Different Data Types
- Data Source Influence on Prescribing Decisions
- Influence of Presentation Frequency on Prescribing
- Decisions
- Networking Role and Value
- MSL Outsourcing
- MSL Clinical Trial Involvement

8. Study Data
- Professional Profile
- Practice Area
- Years in Practice
- Types of Cancer Treated
- Primary Practice Setting
- Patient Volume
- Direct Patient Care
- Professional Perception
- Influence on Others Practicing Oncology
- MSL and Sales Representative Interactions
- Pharmaceutical Sales Representative Interaction Restrictions
- Restrictions on Pharmaceutical Sales Representative Detailing
- Restrictions on Pharmaceutical Sales Representative Detailing – Verbatim Comments
- Most Recent Pharmaceutical Sales Representative Detail
- Satisfaction with Pharmaceutical Sales Representative Interactions
- Pharmaceutical Sales Representative Detail
- Duration with Oncologist
- Pharmaceutical Sales Representative Detail
- Duration with Oncology Practice Manager
- MSL Restriction Level
- Restrictions on MSL Detailing
- Restrictions on MSL Detailing – Verbatim Responses
- Most Recent MSL Detail
- Typical Topics Discussed
- Typical Topics Discussed – Verbatim Comments
- Firms Calling in Past 12 Months
- Satisfaction with MSL Interactions – Categories
- Satisfaction with MSL Interactions – Mean Ratings
- MSL Detail Duration with Oncologist
- MSL Detail Duration with Oncology Practice Manager
- Best MSLs
- Information of Interest to Oncologists
- Information of Interest to Oncologists – Verbatim Comments
- Appropriateness of Topics Discussed
- Networking Role and Value
- Preferred MSL Traits
- Assessing MSL Performance
- Accepting Meeting to Discuss First-in-Class
- Oncology Product
- Accepting Meeting to Discuss a Novel MOA
- Accepting Meeting to Discuss a Transitional or Follow-on Oncology Product
- Preferred Information Delivery Method
- Data Presentation Frequency
- Information Type Influence on Prescribing
- Preferred Information Type by Presenter
- MSL Performance Drill-Down
- - AbbVie
- - Amgen
- - Astellas
- - AstraZeneca
- - Bayer
- - Bristol-Myers Squibb
- - Celgene
- - Eisai
- - Eli Lilly
- - GSK
- - Incyte
- - Johnson & Johnson
- - Merck & Co
- - Novartis
- - Otsuka
- - Pfizer
- - Pharmacyclics
- - Roche
- - Sanofi
- - Takeda
- Prescribing Flexibility
- Influence of Private Payers on Prescribing
- Influence of State and Federal Government Payers on Prescribing
- Future Prescribing Environment
- Future Prescribing Environment – Verbatim Responses
- Insurance Programs
- Awareness of Insurance Incentive Programs
- Insurance Incentive Program Benefits
- Insurance Incentive Program Benefits – Verbatim Responses
- Insurance Incentive Program Drawbacks
- Insurance Incentive Program Drawbacks – Verbatim Responses
- Impact of Affordable Care Act on Practice
- Impact of Affordable Care Act on Practice – Verbatim Responses
- Accountable Care Organization (ACO) Status
- MSL Outsourcing
- MSL Outsourcing – Verbatim Responses
- MSL Clinical Trial Involvement
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
AbbVie
Amgen
Astellas
AstraZeneca
Bayer
Bristol-Myers Squibb
Celgene
Eisai
Eli Lilly
GSK
Incyte
Johnson & Johnson
Merck & Co.
Novartis
Otsuka
Pfizer
Pharmacyclics
Roche
Sanofi
Takeda
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll